FOXP3 and psoriasis: T regs in psoriasis patients have been reported to have reduced suppressive activity that normalizes with sodium butyrate administration and IL-10 levels and expression of Foxp3, IL-17, and IL-6 in psoriatic skin lesions [82,83].